WAYNE L HOFSTETTER to Precision Medicine
This is a "connection" page, showing publications WAYNE L HOFSTETTER has written about Precision Medicine.
Connection Strength
0.135
-
A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups. Biometrics. 2018 09; 74(3):1095-1103.
Score: 0.092
-
High mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol. 2020 May; 121(6):984-989.
Score: 0.026
-
Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res. 2014 Apr 01; 20(7):1946-54.
Score: 0.017